These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 59937)

  • 1. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.
    Harpel PC; Rosenberg RD
    Prog Hemost Thromb; 1976; 3():145-89. PubMed ID: 59937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
    Fuchs HE; Shifman MA; Pizzo SV
    Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract]   [Full Text] [Related]  

  • 5. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma proteinase inhibitors.
    Travis J; Salvesen GS
    Annu Rev Biochem; 1983; 52():655-709. PubMed ID: 6193754
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study of antithrombin systems during heparin therapy].
    Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
    Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitor and gastric cancer.
    Tsumoto S; Oyabu H; Kageyama T
    Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiological anticoagulants. Current data on the composition, function and clinical value].
    Barkagan ZS; Bishevskii KM
    Lab Delo; 1978; (10):579-87. PubMed ID: 81906
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic studies on platelet antiproteases.
    Nalli G; Majolino I; Fornasari PM; Cattaneo G; Malamani GD; Almasio P; Piovella F; Ascari E
    Haematologica; 1978 Apr; 63(2):156-62. PubMed ID: 79518
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial thrombosis due to antithrombin III deficiency in a Greek family.
    Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C
    Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-antitrypsin, alpha 1-antichymotrypsin and alpha 2-macroglobulin in human liver fluke (opisthorchiasis).
    Changbumrung S; Migasena P; Supawan V; Buavatana T; Migasena S
    Tropenmed Parasitol; 1982 Sep; 33(3):195-7. PubMed ID: 6182657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
    Schwarz HP; Aiginger P; Kuzmits R
    Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].
    Oguri T; Hosoi A
    Rinsho Ketsueki; 1978 Jul; 19(7):940-6. PubMed ID: 81329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protease inhibitors].
    Lambin P
    Rev Fr Transfus Immunohematol; 1980 May; 23(2):147-83. PubMed ID: 6161406
    [No Abstract]   [Full Text] [Related]  

  • 17. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
    Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
    Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III, alpha 2-macroglobulin, alpha 1-antitrypsin and plasminogen in childhood diabetes].
    Kotschy M; Wasikowa R; Iwanicka Z; Ciosek W
    Pol Tyg Lek; 1984 Apr; 39(18):611-3. PubMed ID: 6085653
    [No Abstract]   [Full Text] [Related]  

  • 20. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
    Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.